Soleo Health Selected as Authorized Specialty Pharmacy for QIVIGY

The Texas-based provider will offer the primary humoral immunodeficiency treatment.

Apr. 1, 2026 at 12:51pm

Got story updates? Submit your updates here. ›

Soleo Health, a national specialty pharmacy provider, has been selected as an authorized specialty pharmacy to dispense QIVIGY, a new treatment for primary humoral immunodeficiency. The Frisco, Texas-based company will now be able to offer this specialized medication to patients across the country.

Why it matters

This partnership expands access to a critical new therapy for patients with primary humoral immunodeficiency, a rare and serious condition that affects the body's ability to fight infections. Soleo Health's selection as an authorized specialty pharmacy highlights its expertise in delivering complex medications and providing comprehensive patient support.

The details

QIVIGY is a recently approved treatment for primary humoral immunodeficiency, a group of rare disorders where the body does not produce enough antibodies to fight off infections. As an authorized specialty pharmacy, Soleo Health will be responsible for dispensing the medication, providing patient education, and coordinating care with healthcare providers.

  • Soleo Health was selected as an authorized specialty pharmacy for QIVIGY on April 1, 2026.

The players

Soleo Health

A national specialty pharmacy provider headquartered in Frisco, Texas that specializes in delivering complex medications and supporting patients with rare and chronic conditions.

QIVIGY

A newly approved treatment for primary humoral immunodeficiency, a group of rare disorders where the body does not produce enough antibodies to fight off infections.

Got photos? Submit your photos here. ›

The takeaway

This partnership between Soleo Health and the QIVIGY treatment highlights the important role specialty pharmacies play in expanding access to innovative therapies for patients with rare and complex conditions.